Status:
UNKNOWN
TAO Outpatient Trial for Anxiety and Depression
Lead Sponsor:
TAO Connect, Inc.
Conditions:
Anxiety Disorders
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Access to effective treatment resources is a ubiquitous problem in behavioral health. There is a need for effective interventions that are more easily accessed at a lower cost. This study will compare...
Detailed Description
Access to effective treatment resources is a ubiquitous problem in behavioral health. There is a need for effective interventions that are more easily accessed at a lower cost. This stud will compare ...
Eligibility Criteria
Inclusion
- Clients in their first month of treatment with any primary or secondary diagnosis of depression or anxiety. This includes all forms of depression and/or anxiety disorder.
Exclusion
- Chronic depression with a Likely Utilization of Services Instrument (LUSI) designation of "high" or "consistent user" of services. These clients should be referred to Illness Management Recovery.
- Clients with schizophrenia, or any other form of active psychosis.
- Clients with substance dependence disorder.
- Clients with personality disorders.
- Clients whose intellectual functioning would prevent understanding the TAO system and materials.
- Client must not have been in treatment for anxiety and depression in the past three months.
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03390218
Start Date
January 15 2018
End Date
December 1 2018
Last Update
January 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weber Human Services
Ogden, Utah, United States, 84401